Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
The global Choroidal Neovascularization market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Choroidal Neovascularization volume and value at global level, regional level and company level. From a global perspective, this report represents overall Choroidal Neovascularization market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Valeant Pharmaceuticals International Inc.
Gilead Sciences Inc
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Intravenous
Intravitreal
Segment by Application
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Table of Contents
Executive Summary
1 Choroidal Neovascularization Market Overview
1.1 Product Overview and Scope of Choroidal Neovascularization
1.2 Choroidal Neovascularization Segment by Type
1.2.1 Global Choroidal Neovascularization Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Intravenous
1.2.3 Intravitreal
1.3 Choroidal Neovascularization Segment by Application
1.3.1 Choroidal Neovascularization Consumption Comparison by Application (2014-2025)
1.3.2 Extreme Myopia
1.3.3 Malignant Myopic Degeneration
1.3.4 Age-Related Developments
1.4 Global Choroidal Neovascularization Market by Region
1.4.1 Global Choroidal Neovascularization Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Choroidal Neovascularization Market Size
1.5.1 Global Choroidal Neovascularization Revenue (2014-2025)
1.5.2 Global Choroidal Neovascularization Production (2014-2025)
2 Global Choroidal Neovascularization Market Competition by Manufacturers
2.1 Global Choroidal Neovascularization Production Market Share by Manufacturers (2014-2019)
2.2 Global Choroidal Neovascularization Revenue Share by Manufacturers (2014-2019)
2.3 Global Choroidal Neovascularization Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Choroidal Neovascularization Production Sites, Area Served, Product Types
2.5 Choroidal Neovascularization Market Competitive Situation and Trends
Summary: Get latest Market Research Reports on Choroidal Neovascularization . Industry analysis & Market Report on Choroidal Neovascularization is a syndicated market report, published as Global Choroidal Neovascularization Market Research Report 2019. It is complete Research Study and Industry Analysis of Choroidal Neovascularization market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.